Stimuli‐Responsive Nanotechnology for RNA Delivery
Advanced Science · 2023-12 · 10 (36)
DOI: 10.1002/advs.202303597 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, 2023-11. Verfasst von Hui Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Clinical Trial Center, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, 430071, …. Hauptthemen laut MEDLINE: Drug Delivery Systems, Nanoparticles. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Ribonucleic acid (RNA) drugs have shown promising therapeutic effects for various diseases in clinical and preclinical studies, owing to their capability to regulate the expression of genes of interest or control protein synthesis. Different strategies, such as chemical modification, ligand conjugation, and nanotechnology, have contributed to the successful clinical translation of RNA medicine, including small interfering RNA (siRNA) for gene silencing and messenger RNA (mRNA) for vaccine development. Among these, nanotechnology can protect RNAs from enzymatic degradation, increase cellular uptake and cytosolic transportation, prolong systemic circulation, and improve tissue/cell targeting. Here, a focused overview of stimuli‐responsive nanotechnologies for RNA delivery, which have shown unique benefits in promoting RNA bioactivity and cell/organ selectivity, is provided. Many tissue/cell‐specific microenvironmental features, such as pH, enzyme, hypoxia, and redox, are utilized in designing internal stimuli‐responsive RNA nanoparticles (NPs). In addition, external stimuli, such as light, magnetic field, and ultrasound, have also been used for controlling RNA release and transportation. This review summarizes a wide range of stimuli‐responsive NP systems for RNA delivery, which may facilitate the development of next‐generation RNA medicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Clinical Trial Center, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, 430071, Wuhan, China.
- Center for Nanomedicine and Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
- State Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, 210023, Nanjing, China.
ORCID-Profile: Hui Zhou, Xuechuan Hong, Jinjun Shi, Yuling Xiao
Förderung
- NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- American Lung Association
- National Institutes of Health
Zitieren
APA
Zhou, H., Chen, D. S., Hu, C. J., Hong, X., Shi, J., & Xiao, Y. (2023). Stimuli‐Responsive Nanotechnology for RNA Delivery. Advanced Science, 10(36). https://doi.org/10.1002/advs.202303597
Vancouver
Zhou H, Chen DS, Hu CJ, Hong X, Shi J, Xiao Y. Stimuli‐Responsive Nanotechnology for RNA Delivery. Advanced Science. 2023;10(36). doi:10.1002/advs.202303597
BibTeX
@article{Zhou2023,
author = {Zhou, Hui and Chen, Dean Shuailin and Hu, Caleb J and Hong, Xuechuan and Shi, Jinjun and Xiao, Yuling},
title = {Stimuli‐Responsive Nanotechnology for RNA Delivery},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {36},
doi = {10.1002/advs.202303597}
}
EUVIMED